Integra LifeSciencesIART
About: Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Employees: 3,946
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
3,790% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $345K
23% more capital invested
Capital invested by funds: $1.24B [Q3] → $1.54B (+$291M) [Q4]
12% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 67
3% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 40
3.0% less ownership
Funds ownership: 90.75% [Q3] → 87.75% (-3.0%) [Q4]
4% less funds holding
Funds holding: 222 [Q3] → 214 (-8) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for IART.
Financial journalist opinion
Based on 3 articles about IART published over the past 30 days
